Conference Reports for NATAP

Conference on Retroviruses and Opportunistic Infections (CROI) February 13-16, 2017, Seattle WA Back

Randomized Trial of Bictegravir or Dolutegravir with FTC/TAF for Initial HIV Therapy       Reported by Jules Levin CROI 2017 Feb 14-15 Seattle, WA   WEBCAST: http://www.croiwebcasts.org/console/player/33378?mediaType=slideVideo&